mobilities. 8 The three isoforms, commonly called V1, V2, and V3, appear to consist of identical pairs of MLC, and MLC, but differ in the composition of the MHC.8 Two identical a-MHCs are found in V1; two identical ,B-MHCs are found in V3; and heterologous heavy chains, one a-MHC and one f3-MHC, are associated with V2. 1, 5, 8 The proportions of the ventricular isomyosins vary depending on the species of animal, the developmental stage, and pathophysiological status of the heart.1"9-12 In the ventricles of small mammals such as the rat, V3 predominates in the fetus, whereas V, predominates in the adult. The V3 form reappears in animals undergoing cardiac enlargement. '3 In large mammals, such as humans, the V3 isomyosin predom-inates5 and appears not to vary to any great extent with cardiac enlargement. 14"15 Ventricular myosin isotype composition has been studied previously'6 in patients with tetralogy of Fallot. It was found that ALC1, which is normally present in the fetal ventricle, where it declines during development and disappears by the first year after birth, was present not only in fetal but also in neonatal and adult ventricles of tetralogy of Fallot patients. No evidence of MHC transitions was seen in the ventricles of these patients.
It has been demonstrated that a transition from atrialto ventricular-type MLCs occurs in the atria of adults with cardiovascular disorders characterized by pressure overload.12 The degree of transition was related to the severity of pressure overload. '7 In the present study, we examined the myosin subunits in the atria of children with congenital heart disease by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), peptide mapping, and Western blot analysis to see whether there were myosin isoform transitions and, if so, whether they correlated with pressure and/or volume overload. 
Materials and Methods

Electrophoretic Analysis
ALCs were analyzed by two-dimensional gel electrophoresis. Atrial cytoplasmic proteins were fractionated by isoelectric focusing followed by 10% SDS-PAGE in the second dimension, as described earlier.'8 The proteins were visualized using the silver staining technique.'9 Atrial MHC isotypes were analyzed by one-dimensional gel electrophoresis using a modification of the procedure of Carraro and Catani.20 Proteins on gels were stained with Coomassie blue.
Peptide Mapping
The peptide mapping of the electrophoretically purified MHC and MLC was performed according to Cleveland et al. 21 The MHC and MLC bands were stained briefly with Coomassie blue, cut out, equilibrated in 125 mM Tris-HCl (pH 6.8), 0.1% SDS, and 1 mM EDTA, and loaded onto polyacrylamide gel (15% for MLC and 7.5% for MHC). Samples for digestion were overlaid directly with a solution containing 50 ng Staphylococcus aureas V8 protease. Electrophoresis was carried out at a constant current of 20 mA. The gels were stained with silver. 19 Westem Blot Analysis Atrial cytoplasmic proteins from 15 children expressing VLCs and five not expressing VLCs in their atria were separated on 10% Laemmli22 gels. MHCs were separated as described earlier. Electrophoretic transfer was based on the original method of Towbin et al. 23 Rabbit antisera to human VLCs24 were used to detect the presence of VLCs in atrial biopsies. A monoclonal antibody specific to human f,-MHC was used to distinguish ,B-MHC from a-MHC. A colorimetric assay using horseradish peroxidase (GAR-HRP, Bio-Rad Laboratories, Richmond, Calif.) was used to detect the binding of antibody to antigen.
Results
Two-dimensional PAGE analysis of cytoplasmic proteins from right atrial appendage biopsies of (Figure 2 ). Both the putative VLC2 and normal VLC2 gave identical peptide patterns, which were clearly different from that of ALCs and VLC1. Polyclonal antibodies to human VLCs were used for Western blot analysis of atrial cytoplasmic proteins. Although these antibodies also cross-reacted with ALC1, one can easily distinguish VLC1 from ALC1 by comparing their electrophoretic mobilities with those of purified VLCs and ALCs. The results showed that all 15 samples that showed VLCs by electrophoresis were also recognized by our VLC antibodies, whereas the five samples that didn't show VLCs by electrophoresis were negative. As seen in Figure 3 , VLCs were present in all three samples (lanes 3, 6, and 7) that were taken from children with either ventricular septal defects or tetralogy of Fallot. seen in lanes 4 (pulmonary stenosis) and 5 (transposition of great vessels) in Figure 3 . These results are also consistent with the electrophoretic findings.
Based on electrophoretic mobility, peptide mapping, and Western blot analysis, our study shows that the new proteins found in the atria of children with congenital heart disease are indeed VLCs.
To determine the MHC composition in the atria of children with congenital heart disease, we had to identify and characterize the MHC components from normal ventricular and atrial myosin. Modifying the sensitive procedure of Carraro and Catani20 for the separation of skeletal MHC isoforms of cardiac tissue, we were able for the first time to electrophoretically separate and characterize ventricular MHC (,B-MHC) and atrial MHC (a-MHC) ( Figure 4 ). Ventricular ,-MHC migrates slightly faster than the atrial a-MHC. Atrial cytoplasmic proteins from children with ventricular septal defects expressing VLCs and from children not expressing VLCs, when analyzed for MHC, were indistinguishable from each other. However, they all comigrated with atrial a-MHC. This method is very sensitive, allowing one to detect a 2% contamination in a mixture of MHC. 20 To determine whether the band that comigrated with a-MHC was indeed a-MHC and not f3-MHC, the band was cut out and digested with S. aureus V8 protease. The resultant peptide maps indicate that the MHC being expressed in children with VLCs in their atria is identical to atrial a-MHC and clearly differs from ventricular /-MHC ( Figure 5 ). We have isolated human ventricular MHC and raised monoclonal antibodies to it. By using the gel system described above for the separation of a-and 13-MHC, Western blot analysis was performed ( 
Discussion
The present study is the first comprehensive study of the myosin subunit patterns in the atria of patients with different congenital heart diseases. The presence of VLCs in the atria of these children was demonstrated by electrophoresis, peptide mapping, and Western blot analysis. The presence of VLCs in the atria was particularly common in children with perimembranous ventricular septal defects and tetralogy of Fallot. Our results differ from the results of studies in adult patients performed by Cummins.12 He demonstrated that VLC2 was the major species in hypertrophied atria, although VLC, subsequently appeared in severe pressure-overload hypertrophy cases. In our studies, VLC, was present in 15 children (Table 1 ) who did not express VLC2, and the presence of VLCs was not correlated with pressure or volume overload. The majority of the children with VLCs had normal cardiac hemodynamic parameters. Our results suggest that the expressions of VLC1 and VLC2 are regulated independently and that they are induced in these children by a factor other than pressure or volume overload.
It has been shown that in the spontaneously hypertensive rat VLC2 is present in the atria and that the increased expression of the VLC2 gene of spontaneously hypertensive rat atria is a predetermined event, since VLC2 messenger RNA is present even in 6-week-old spontaneously hypertensive rat atria, where there is no established overloading of the heart. 25 In our studies, the right atrial mean pressure of children with VLCs and children without VLCs in their atria is 3.5 and 3.8 mm Hg, respectively ( Table 2 ). The lack of correlation between the presence of VLCs in the atria and hemodynamic parameters indicates that the expression of VLCs may be a predetermined event FIGURE 6. Panel A: Silver staining of the myosin heavy chain region of a sodium dodecyl sulfate-polyacrylamide geL Panel B: Immunoreactivity of the myosin heavy chain region of a sodium dodecyl sulfate-polyacrylamide gel with antibody to ventricular myosin heavy chain (f3-myosin heavy chain). 1, Total atrial cytoplasmic protein from a child with ventricular septal defects expressing ventricular light chains; 2, purified human atrial myosin heavy chain (a-myosin heavy chain); 3, punfied human ventricular myosin heavy chain. 2 3 rather than an event induced directly by pressure overload.
Most studies on cardiac isomyosin transitions in humans or in animals under various pathological conditions have dealt with the analysis of either intact native myosin or the light chains, since they can readily be separated and characterized electro-phoretically9-12,14,15 (the native myosin by pyrophosphate gel electrophoresiss and the light chains by two-dimensional PAGE" 1,12). Characterization of specific MHCs has been based mainly on the use of specific antibodies against either the a-or fB-MHC and proteolytic mapping (in the presence of SDS) of the whole myosin molecule,"'04'415 since conventional SDS-PAGE in the past has failed to distinguish between a-and f3-MHC. (For an excellent review on this topic see Reference 26) .
Analysis of MHC isotypes in the atria of children with congenital heart disease by electrophoresis, peptide mapping, and Western blot indicated that there was no detectable f-MHC, which is normally associated with VLCs. In hemodynamically overloaded adult human atria, both MHC and MLC isotype transitions occur.'2 Our immunohistochemical studies revealed that VLCs were expressed in the same cell in which ALCs were expressed, indicating that a myosin molecule with a-MHC and VLCs was present. 27 These results were consistent with the finding of Lyons et al,28 who demonstrated that the genes for MHCs and MLCs were not coordinately expressed during cardiac development.
Recent results obtained by Bugaisky et a129 have demonstrated a high degree of heterogeneity in myosin isoform expression throughout a given layer and in different regions of the myocardium. This variability illustrates a potential danger in interpretation of gel results obtained from a single small tissue sample. The MLC and MHC patterns reported here may only represent changes in the right atrial appendage and not in the right atrium as a whole. It is not clear at present how cardiac MLCs are regulated and which transacting factors are involved in the regulation of tissue-specific gene expression. It is also unexplained why some children with congenital heart disease have an MLC transition in their atria and others do not. Further understanding is dependent on the understanding of fine gene structures of cardiac MLCs, in particular the upstream regulatory region, and of the regulatory mechanisms of this gene family.
